The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was ...

Young children in sub-Saharan Africa often become severely anemic as consequence of a malaria infection. Treating them requires blood transfusions and they must stay hospitalized for several days.

​The newly prequalified treatment—artemether-lumefantrine — is the first antimalarial formulation designed specifically for the youngest malaria patients. It can be used for newborns and young infants ...

Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...

The first malaria drug for newborn babies and those weighing less than 11 pounds has been approved by Swiss medical authorities in a move that could fill a treatment gap for some of those most ...

His malaria vaccination appointment at a clinic in central Cameroon was too important to miss. For decades, millions of ...

A clinical trial by Menzies School of Health Research (Menzies) published in The Lancet has revealed promising results to reduce malaria relapses, through the broader use of primaquine. Primaquine is ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

Gujarat Health Department launches a massive state-wide campaign to combat vector-borne diseases. Discover how 19,500 health ...

An experimental antibody treatment prevented malaria in the majority of participants in a small but important new study, providing a measure of hope in the effort to lower the burden of the disease ...

India is witnessing an early rise in monsoon-related illnesses, with dengue, malaria, leptospirosis and seasonal viral fevers ...

A 15-year study suggests that long-term malaria control may depend as much on protecting environments as it does on ...